Krystal Biotech KRYS
NASDAQ KRYS
$306.51 -2.30 (-0.75%)
As of: Nov 12, 2026 · 9:42 AM EST

Krystal Biotech (KRYS) Return on Capital Employed [ROCE] (2017 - 2026)

Updated

Krystal Biotech's Return on Capital Employed [ROCE] came in at 16.24% for Q3 2026, up 1.81 percentage points from 14.43% a year earlier and up 1.27 percentage points from the prior quarter.

Analysis

Krystal Biotech (KRYS) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends

For FY2025, Krystal Biotech's Return on Capital Employed [ROCE] was 14.77%, up 6.90 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased in each of the last three years, with a five-year change of +28.27 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was 7.87% in FY2024 (+24.60 pp), -16.73% in FY2023 (+9.04 pp), -25.77% in FY2022 (-10.35 pp) and -15.42% in FY2021 (-1.92 pp).
  • The Q3 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2017.
  • Year-over-year, Return on Capital Employed [ROCE] has increased for 13 consecutive quarters, with an average year-over-year change of +10.15 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 24.01 percentage points), and the weakest in Q4 2022 (a drop of 13.65 percentage points).
  • Business Quant data shows KRYS's Return on Capital Employed [ROCE] at 14.97% (Q2 2026), 14.21% (Q1 2026) and 13.62% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Krystal Biotech 9.08 Bn 5.67 Bn 119.79 Mn 16.24%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 16.24%
Jun 30, 2026 14.97%
Mar 31, 2026 14.21%
Dec 31, 2025 13.62%
Sep 30, 2025 14.43%
Jun 30, 2025 13.68%
Mar 31, 2025 11.02%
Dec 31, 2024 7.17%
Sep 30, 2024 3.21%
Jun 30, 2024 -2.56%
Mar 31, 2024 -8.56%
Dec 31, 2023 -14.21%
Sep 30, 2023 -20.81%
Jun 30, 2023 -26.21%
Mar 31, 2023 -28.19%
Dec 31, 2022 -26.96%
Sep 30, 2022 -23.59%
Jun 30, 2022 -20.27%
Mar 31, 2022 -18.56%
Dec 31, 2021 -13.31%
API Access

Krystal Biotech Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KRYS&period=max&api_key=YOUR_API_KEY